(Q38792113)

6 September 2017

Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin (English)

1 reference

6 September 2017

1 reference

Yiming Zhang

1

1 reference

6 September 2017

Zhong Jin

2

1 reference

6 September 2017

Huimin Zhou

3

1 reference

6 September 2017

Xueting Ou

4

1 reference

6 September 2017

Yawen Xu

5

1 reference

6 September 2017

Hulin Li

6

1 reference

6 September 2017

Chunxiao Liu

7

1 reference

6 September 2017

Bingkun Li

8

1 reference

6 September 2017

language of work or name

English

0 references

publication date

21 February 2016

1 reference

6 September 2017

1 reference

6 September 2017

5

1 reference

6 September 2017

6

1 reference

6 September 2017

1251-1258

1 reference

Insights into Chemoresistance of Prostate Cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Therapy escape mechanisms in the malignant prostate

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Suppression of cancer relapse and metastasis by inhibiting cancer stemness

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

6 September 2017

Cancer statistics, 2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Docetaxel (Taxotere)-based chemotherapy for hormone-refractory and locally advanced prostate cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

Prostate cancer stem cells

14 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCAM4.675

Prostate cancer stem cells: a target for new therapies

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4924383

3 December 2018

Identifiers

DOI

10.1002/CAM4.675

1 reference

6 September 2017

1 reference

6 September 2017

PubMed publication ID

26899963

1 reference